As of November 6, 2026, PROCEPT BioRobotics Corp is a publicly traded company (Nasdaq: PRCT); its largest reported holder is BlackRock, with 8.2% on Schedule 13G/A of July 29, 2026, then T. Rowe Price (5.9%). The largest insider holding is Frederic H. Moll, a director, with 866,474 shares (1.5% of shares outstanding), per Form 4 of June 10, 2026 (Schedule 13G/A, July 29, 2026).
Is this your company?
About to sign with, pay or invest in PROCEPT BioRobotics Corp? See the free Snapshot first.
Free to see. No signup.
Is PROCEPT BioRobotics Corp a real, registered company?
- Procept Biorobotics Corp files with the SEC under CIK 1588978 (its SEC filings).
- Its shares are listed under the ticker PRCT on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in San Jose, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Procept Biorobotics Corp in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Michael Mack, Director (Form 8-K filed 2026-10-02). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-07-29).
Who are PROCEPT BioRobotics Corp's owners and officers?
PROCEPT BioRobotics Corp: incorporated in Delaware; business address in San Jose, California; industry Surgical & Medical Instruments & Apparatus (Schedule 13G/A, 2026-10-30).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-10-30 | Vanguard Capital Management | 4.96% |
| Schedule 13G/A, 2026-07-29 | Blackrock, Inc. | 8.2% |
| Schedule 13G/A, 2026-05-18 | Alliancebernstein L.P. | 0.3% |
| Schedule 13G, 2026-04-30 | Vanguard Capital Management | 5% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-03-06 | Fmr LLC | 2.9% |
| Schedule 13G, 2026-02-17 | T. Rowe Price Investment Management, Inc. | 5.9% |
| Schedule 13G, 2026-02-11 | Bnp Paribas Asset Management Holding S.A. | 5.5% |
| Schedule 13G/A, 2026-01-08 | Fmr LLC | 8.3% |
| Schedule 13G, 2025-11-14 | Alliancebernstein L.P. | 6.1% |
Questions about who owns PROCEPT BioRobotics Corp
Who owns PROCEPT BioRobotics Corp?
On this page, 3 holders' latest ownership filings report 5% or more of PROCEPT BioRobotics Corp: Blackrock, Inc. (8.2%, Schedule 13G/A, filed 2026-07-29), T. Rowe Price Investment Management, Inc. (5.9%, Schedule 13G, filed 2026-02-17) and Bnp Paribas Asset Management Holding S.A. (5.5%, Schedule 13G, filed 2026-02-11).
Who are the largest shareholders of PROCEPT BioRobotics Corp?
By the share each holder's latest filing reports, the largest holders of PROCEPT BioRobotics Corp on this page are Blackrock, Inc. (8.2%), T. Rowe Price Investment Management, Inc. (5.9%) and Bnp Paribas Asset Management Holding S.A. (5.5%).
When did Blackrock, Inc. buy into PROCEPT BioRobotics Corp?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2026-07-29, reporting 8.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on PROCEPT BioRobotics Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on PROCEPT BioRobotics Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PROCEPT BioRobotics Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-02 | Michael Mack | Director | appointed |
Which insiders own PROCEPT BioRobotics Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 866,474 shares (1.5% of shares outstanding) (Form 4, 2026-06-10).
- , the chief executive and president: 338,103 shares (0.59% of shares outstanding), 314,203 held directly and 23,900 indirectly (Form 4, 2026-08-10).
- , the chief executive and president: 186,829 shares (0.32% of shares outstanding) (Form 4, 2025-05-13).
- , the chief financial officer and executive vice president: 180,355 shares (0.31% of shares outstanding) (Form 4, 2026-09-10).
- , the executive vice president and chief legal officer: 127,737 shares (0.22% of shares outstanding) (Form 4, 2026-09-10).
Shares outstanding: 57,536,121 as of 2026-10-29, from the company's latest SEC cover page.
How much has PROCEPT BioRobotics Corp raised?
No fundraising or offering filing from PROCEPT BioRobotics Corp is on file with us.
Keep reading
More on PROCEPT BioRobotics Corp and the records around it.
PROCEPT BioRobotics Corp elsewhere on the record
- Leadership changes Oct 2026
Companies that share a holder
- BNP Paribas Asset Management Holding S.A. also filed stake reports on 1 other company: Array Technologies, Inc. (Apr 2026)
- AllianceBernstein L.P. also filed stake reports on 82 other companies: New Fortress Energy Inc (Nov 2026), RIVERNORTH OPPORTUNITIES FUND, INC. (Oct 2026), Trex Co Inc (Sep 2026)
- T. Rowe Price Investment Management, Inc. also filed stake reports on 167 other companies: CABALETTA BIO INC (Nov 2026), MADISON SQUARE GARDEN SPORTS CORP (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/procept-biorobotics